1.Feger, J, Hassani, O, Mouroux, M. The subthalamic nucleus and its connections. New electrophysiological and pharmacological data. Adv Neurol 1997;74:31–43.
2.DeLong, M. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281–85.
3.Wichmann, T, Bergman, H, DeLong, M. The primate subthalamic nucleus. I. Functional properties in intact animals. J Neurophysiol 1994;72(2):494–506.
4.Robledo, P, Feger, J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res 1990;51(8):47–54.
5.Kita, H, Kitai, S. Intracellular study of rat globus pallidus neurons: membrane properties and responses to neostriatal, subthalamic and nigral stimulation. Brain Res 1991;564:296–305.
6.Hammond, C, Deniau, J, Rizk, A, Feger, J. Electrophysiological demonstration of an excitatory subthalamonigral pathway in the rat. Brain Res 1978;151:235–44.
7.Monakow, KH, Akert, K, Kunzle, H. Projections of the precentral motor cortex and other cortical areas of the frontal lobe to the subthalamic nucleus in the monkey. Exp Brain Res 1978;33:395–403.
8.Nambu, A, Takada, M, Inase, M, et al. Dual somatotopical representations in the primate subthalamic nucleus: evidence for ordered but reversed body-map transformations from the primary motor cortex and the supplementary motor area. J Neurosci 1996;16:2671–83.
9.Romanelli, P, Heit, G, Hill, BC, et al. Microelectrode recording revealing a somatotopic body map in the subthalamic nucleus in humans with Parkinson disease. J Neurosurg 2004;100:611–18.
10.Miller, W, DeLong, M. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. Carpenter, MB, Jayaraman, A, eds. The Basal Ganglia II. Structure and Function – Current Concepts. New York: Plenum Press, 1987.
11.Filion, M, Tremblay, L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:142–51.
12.Bergman, H, Wichmann, T, Karmon, B, DeLong, M. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994;72:507–20.
13.Bergman, H, Wichmann, T, DeLong, M. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436–38.
14.Lozano, A, Hutchison, W, Kiss, Z, et al. Methods for microelectrode-guided posteroventral pallidotomy. J Neurosurg 1996;84:192–202.
15.Vitek, J, Bakay, R, Hashimoto, T, et al. Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease. J Neurosurg 1998;88:1027–43.
16.Bezard, E, Boraud, T, Bioulae, B, Gross, C. Presymptomatic revelation of experimental Parkinsonism. Neuro Rep 1997;8:435–38.
17.Lenz, FA, Tasker, RR, Kwan, HC, et al. Single unit analysis of the human ventral thalamic nuclear group: correlation of thalamic “tremor cells” with the 3–6 Hz component of parkinsonian tremor. J Neurosci 1988;8:754–64.
18.Brown, P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord 2003;18(4):357–63.
19.Bronte-Stewart, H, Barberini, C, Miller Koop, M, et al. The STN beta band profile in Parkinson's disease is stationary and shows prolonged attenuation after deep brain stimulation. Exp Neurol 2009;215:20–28.
20.McIntyre, CC, Grill, WM, Sherman, DL, et al. Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition. J Neurophysiol 2004;91:1457–69.
21.Ondo, W, Bronte-Stewart, H. The North American survey of placement and adjustment strategies for deep brain stimulation. Stereotact Funct Neurosurg 2005;83(4):142–47.
22.Holloway, KL, Gaede, SE, Starr, PA, et al. Frameless stereotaxy using bone fiducial markers for deep brain stimulation. J Neurosurg 2005;103(3):404–13.
23.Svennilson, E, Torvik, A, Lowe, R, Leksell, L. Treatment of Parkinsonism by stereotactic thermolesions in the pallidal region. Acta Psychiat Scand 1960;35:358–77.
24.Vitek, J, Bakay, R, DeLong, M. Microelectrode-guided pallidotomy for medically intractable Parkinson's disease. Adv Neurol 1997;74:183–98.
25.Gross, R, Lombardi, W, Lang, A, et al. Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease. Brain 1999;122:405–16.
26.Eskandar, E, Cosgrove, G, Shinobu, L, Penney, J. The importance of accurate lesion placement in posteroventral pallidotomy: report of two cases. J Neurosurg 1998;89:630–34.
27.Bronte-Stewart, H, Hill, B, Molander, M, et al. Lesion location predicts clinical outcome of pallidotomy. Mov Disord 1998;13:300.
28.Romanelli, P, Bronte-Stewart, HM, Heit, G, Schaal, DW, Vincenzo, E. The functional organization of the sensorimotor region of the subthalamic nucleus. Stereotact Funct Neurosurg 2004;82:222–29.
29.Haynes, WIA, Haber, SN. The organization of prefrontal–subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for basal ganglia models and deep brain stimulation. J Neurosci 2013;33(11):4804–14.
30.Starr, PA, Vitek, JL, DeLong, M, Bakay, RA. Magnetic resonance imaging-based stereotactic localization of the globus pallidus and subthalamic nucleus. Neurosurgery 1999;44(2):303–13.
31.Bejjani, BP, Dormont, D, Pidoux, B, et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 2000;92(4):615–25.
32.Cuny, E, Grehl, D, Burbaud, P, et al. Lack of agreement between direct magnetic resonance imaging and statistical determination of a subthalamic target: the role of electrophysiological guidance. J Neurosurg 2002;97:591–97.
33.Okun, MS, Vitek, JL. Lesion therapy for Parkinson's disease and other movement disorders: update and controversies. Mov Disord 2004;19(4):375–89.
34.The Deep Brain Stimulation for Parkinson's Disease Study Group. Deep brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. New Engl J Med 2001;345:956–63.
35.Binder, DK, Rau, GM, Starr, PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 2005;6(4):722–32.
36.Miller Koop, M, Andrzejewski, A, Hill, BC, Heit, G, Bronte-Stewart, HM. Improvement in a quantitative measure of bradykinesia after microelectrode recording in patients with Parkinson's disease during deep brain stimulation surgery. Mov Disord 2006;21(5):673–78.
37.Bejjani, B, Damier, P, Arnulf, I, et al. Pallidal stimulation for Parkinson's disease. Two targets? Neurology 1997;49:1564–69.
38.Pollak, P, Benabid, AL, Krack, P, et al. Deep brain stimulation. In Jancovic, J, ed., Parkinson's Disease and Movement Disorders. Baltimore: Williams and Wilkins, 1998.
39.Okun, MS, Tagliati, M, Pourfar, M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005;62(8):1250–55.